Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.
FDA Issues Complete Response Letter for Abeona's Pz-cel for Epidermolysis Bullosa
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and More
ReV Up Your Vitiligo Treatment Strategies
QUIZ: Test Your Knowledge of Rosacea Treatment Modalities and the Therapeutic Landscape
European Union Approves Bimekizumab to Treat HS